False Commercial Billing

Whistleblower Helps DOJ Settle Biopharmaceutical Company False Claims Act Charges of False Commercial Billing Practices for $6.5 Million

Posted on by Simon Mikail
Category: Federal False Claims, Whistleblower Attorney, Whistleblower Claim, Whistleblower Protection
The US District of Justice announced on April 6, 2020, that MiMedx Group Inc. (MiMedx) is based in Georgia made and sold human tissue grafts. The payment settles a claim brough by a whistleblower under the qui tam provisions of the False Claims act. The whistleblower was a sales representative. The False Claims Act per...